FDA finalizes guidance on food effect studies, issues draft on contamination prevention for non-penicillin beta-lactam drugs
Regulatory NewsJeff Craven
Chemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaPharmaceuticalsProduct Lifecycle